139 related articles for article (PubMed ID: 28837879)
1. Telmisartan ameliorates adipoR1 and adipoR2 expression via PPAR-γ activation in the coronary artery and VSMCs.
Shen X; Li H; Li W; Wu X; Sun Z; Ding X
Biomed Pharmacother; 2017 Nov; 95():129-136. PubMed ID: 28837879
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
3. Effect of Telmisartan or Insulin on the Expression of Adiponectin and its Receptors in the Testis of Streptozotocin-Induced Diabetic Rats.
Guo Z; Yan X; Wang L; Wu J; Jing X; Liu J
Horm Metab Res; 2016 Jun; 48(6):404-12. PubMed ID: 26849825
[TBL] [Abstract][Full Text] [Related]
4. Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats.
Guo Z; Zhang R; Li J; Xu G
Cardiovasc Diabetol; 2012 Aug; 11():94. PubMed ID: 22873349
[TBL] [Abstract][Full Text] [Related]
5. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats.
Guo Z; Zheng C; Qin Z; Wei P
J Pharm Pharmacol; 2011 Jan; 63(1):87-94. PubMed ID: 21155820
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
[TBL] [Abstract][Full Text] [Related]
8. Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice.
Ushijima K; Takuma M; Ando H; Ishikawa-Kobayashi E; Nozawa M; Maekawa T; Shiga T; Fujimura A
Eur J Pharmacol; 2013 Jan; 698(1-3):505-10. PubMed ID: 23195328
[TBL] [Abstract][Full Text] [Related]
9. Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes.
Goyal S; Arora S; Bhatt TK; Das P; Sharma A; Kumari S; Arya DS
Chem Biol Interact; 2010 May; 185(3):271-80. PubMed ID: 20307515
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome.
Rinaldi B; Di Filippo C; Capuano A; Donniacuo M; Sodano L; Ferraraccio F; Rossi F; D'Amico M
Diabetes Obes Metab; 2012 Apr; 14(4):320-8. PubMed ID: 22050607
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma expression in the lung tissue of obese rats.
Hwang SJ; Kim JH; Shim JW; Kim DS; Jung HL; Park MS; Lee WY; Kim SY; Shim JY
Yonsei Med J; 2011 May; 52(3):495-501. PubMed ID: 21488194
[TBL] [Abstract][Full Text] [Related]
13. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
[TBL] [Abstract][Full Text] [Related]
14. Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
Nagashima A; Watanabe R; Ogawa M; Suzuki J; Masumura M; Hishikari K; Shimizu T; Takayama K; Hirata Y; Nagai R; Isobe M
J Cardiovasc Pharmacol; 2012 Aug; 60(2):158-64. PubMed ID: 22561360
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan protects against vascular dysfunction with peroxisome proliferator-activated receptor-γ activation in hypertensive 5/6 nephrectomized rats.
Toba H; Wang J; Ohigashi M; Kobara M; Nakata T
Pharmacology; 2013; 92(5-6):265-75. PubMed ID: 24281041
[TBL] [Abstract][Full Text] [Related]
16. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Song KH; Park JH; Jo I; Park JY; Seo J; Kim SA; Cho DH
Vascul Pharmacol; 2016 Mar; 78():43-52. PubMed ID: 26455386
[TBL] [Abstract][Full Text] [Related]
18. Different effects of telmisartan and valsartan on human aortic vascular smooth muscle cell proliferation.
Wang L; Zhao L; Zhang D; Chen JZ; Xue JL
Chin Med J (Engl); 2012 Jun; 125(12):2200-4. PubMed ID: 22884153
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
Toba H; Tojo C; Wang J; Noda K; Kobara M; Nakata T
Eur J Pharmacol; 2012 Jun; 685(1-3):91-8. PubMed ID: 22314223
[TBL] [Abstract][Full Text] [Related]
20. Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake.
Saito Y; Fujioka D; Kawabata K; Kobayashi T; Yano T; Nakamura T; Kodama Y; Takano H; Kitta Y; Obata JE; Kugiyama K
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3490-7. PubMed ID: 17906114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
